DeFeo ML - Search Results

1

Opioid modulation of normal and pathological human chromaffin tissue.

Mannelli M, Maggi M, DeFeo ML, Boscaro M, Opocher G, Mantero F, Baldi E, Giusti G. Mannelli M, et al. Among authors: defeo ml. J Clin Endocrinol Metab. 1986 Mar;62(3):577-82. doi: 10.1210/jcem-62-3-577. J Clin Endocrinol Metab. 1986. PMID: 3003144 Clinical Trial.

2

Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympathetic-adrenal discharge in humans.

Mannelli M, Pupilli C, Fabbri G, Musante R, De Feo ML, Franchi F, Giusti G. Mannelli M, et al. J Clin Endocrinol Metab. 1988 Mar;66(3):626-31. doi: 10.1210/jcem-66-3-626. J Clin Endocrinol Metab. 1988. PMID: 3280589 Clinical Trial.

3

Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.

Mannelli M, Delitala G, De Feo ML, Maggi M, Cuomo S, Piazzini M, Guazzelli R, Serio M. Mannelli M, et al. J Clin Endocrinol Metab. 1984 Jul;59(1):74-8. doi: 10.1210/jcem-59-1-74. J Clin Endocrinol Metab. 1984. PMID: 6725527 Clinical Trial.

4

Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma.

Mannelli M, De Feo ML, Maggi M, Pupilli C, Opocher G, Valenza T, Baldi E, Serio M. Mannelli M, et al. J Endocrinol Invest. 1987 Aug;10(4):377-82. doi: 10.1007/BF03348153. J Endocrinol Invest. 1987. PMID: 2890684

5

Does endogenous dopamine modulate human sympathetic activity through DA2 receptors?

Mannelli M, De Feo ML, Maggi M, Salvetti A, Giusti G, Serio M. Mannelli M, et al. Eur J Clin Pharmacol. 1985;29(2):159-64. doi: 10.1007/BF00547415. Eur J Clin Pharmacol. 1985. PMID: 2934264 Clinical Trial.

6

Naloxone administration does not affect gonadotropin secretion in agonadal men either basally or during testosterone treatment.

De Feo ML, Maggi M, Guardabasso V, Rodbard D, Delitala G, Fazzi V, Genazzani AD, Facchinetti F, Forti G. De Feo ML, et al. J Clin Endocrinol Metab. 1986 Jul;63(1):257-61. doi: 10.1210/jcem-63-1-257. J Clin Endocrinol Metab. 1986. PMID: 3086359 Clinical Trial.

7

Naloxone administration releases catecholamines.

Mannelli M, Maggi M, De Feo ML, Cuomo S, Forti G, Moroni F, Giusti G. Mannelli M, et al. N Engl J Med. 1983 Mar 17;308(11):654-5. doi: 10.1056/NEJM198303173081113. N Engl J Med. 1983. PMID: 6298624 No abstract available.

8

Effects of naloxone on catecholamine plasma levels in adult men. A dose-response study.

Mannelli M, Maggi M, De Feo ML, Cuomo S, Delitala G, Giusti G, Serio M. Mannelli M, et al. Acta Endocrinol (Copenh). 1984 Jul;106(3):357-61. doi: 10.1530/acta.0.1060357. Acta Endocrinol (Copenh). 1984. PMID: 6331037 Clinical Trial.

9

Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas.

Baldi E, De Feo ML, Geppetti P, Carlà V, Maggi M, Pupilli C, Spillantini MG, Brocchi A, Mannelli M. Baldi E, et al. J Endocrinol Invest. 1988 Feb;11(2):133-8. doi: 10.1007/BF03350121. J Endocrinol Invest. 1988. PMID: 2452181

10

Effect of verapamil on catecholamine secretion by human pheochromocytoma.

Mannelli M, DeFeo ML, Maggi M, Geppetti P, Baldi E, Pupilli C, Serio M. Mannelli M, et al. Among authors: defeo ml. Hypertension. 1986 Sep;8(9):813-4. doi: 10.1161/01.hyp.8.9.813. Hypertension. 1986. PMID: 3744473 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters